{
    "clinical_study": {
        "@rank": "112743", 
        "arm_group": [
            {
                "arm_group_label": "Acute kidney injury", 
                "description": "Acute kidney injury in ICU"
            }, 
            {
                "arm_group_label": "Non acute kidney injury", 
                "description": "Non acute kidney injury"
            }
        ], 
        "biospec_descr": {
            "textblock": "Serum BUN, Cre, ICAM-1"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "Indoxyl sulfate (IS) is an anionic uremic toxin that is accumulated in the serum of patients\n      with uremia. In previous study, the investigators successfully induced AKI animal model. IS\n      enhanced intercellular adhesion molecule-1 (ICAM-1) expression in IL-1\u03b2-treated human\n      umbilical vein endothelial cells (HUVECs) that this may play a critical role in the\n      progression of AKI. However, the molecular mechanisms of ICAM-1 expression in IS-treated\n      IL-1\u03b2-treated HUVECs need to be elucidated. HUVECs incubated with 0.2 or 1 mM IS for 24 h\n      did not cause cytotoxicity. The IL-1\u03b2-induced ICAM-1 expression in HUVECs was significantly\n      enhanced by IS pretreatment. Furthermore, the regulation of adhesion molecule expression\n      involves a complex array of intracellular signaling pathways including mitogen-activated\n      protein kinase (MAPKs), reactive oxygen species (ROS) and transcriptional factors. A better\n      understanding of this might provide important insights into the prevention of AKI."
        }, 
        "brief_title": "Indoxyl Sulfate Induces Leukocyte-endothelial Interactions Through Up-regulation of ICAM-1 in Acute Kidney Injury", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Renal Function Disorder", 
        "condition_browse": {
            "mesh_term": "Acute Kidney Injury"
        }, 
        "detailed_description": {
            "textblock": "Over the past decade, acute kidney injury (AKI) has acquired much attention because of their\n      potentially devastating problems in clinical medicine. When kidneys lost their filtering\n      function, a lot of dangerous metabolites were accumulated in the body, including urea,\n      nitrogenous waste products and uremic toxins. Indoxyl sulfate (IS) is an anionic uremic\n      toxin that is accumulated in the serum of patients with uremia. In previous study, the\n      investigators successfully induced AKI animal model. IS enhanced intercellular adhesion\n      molecule-1 (ICAM-1) expression in IL-1\u03b2-treated human umbilical vein endothelial cells\n      (HUVECs) that this may play a critical role in the progression of AKI. However, the\n      molecular mechanisms of ICAM-1 expression in IS-treated IL-1\u03b2-treated HUVECs need to be\n      elucidated. HUVECs incubated with 0.2 or 1 mM IS for 24 h did not cause cytotoxicity. The\n      IL-1\u03b2-induced ICAM-1 expression in HUVECs was significantly enhanced by IS pretreatment.\n      Furthermore, the regulation of adhesion molecule expression involves a complex array of\n      intracellular signaling pathways including mitogen-activated protein kinase (MAPKs),\n      reactive oxygen species (ROS) and transcriptional factors. A better understanding of this\n      might provide important insights into the prevention of AKI."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ICU patients\n\n        Exclusion Criteria:\n\n          -  Less than 20 years old"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "20 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "AKI in ICU"
            }
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 11, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02061566", 
            "org_study_id": "201310062RINA"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Acute kidney injury", 
        "lastchanged_date": "February 23, 2014", 
        "location": {
            "contact": {
                "email": "chouyuhsiang@yahoo.com.tw", 
                "last_name": "Yu-Hsiang Chou, MD", 
                "phone": "+886-972655372"
            }, 
            "facility": {
                "address": {
                    "city": "Taipei", 
                    "country": "Taiwan", 
                    "zip": "100"
                }, 
                "name": "National Taiwan University Hospital"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_groups": "2", 
        "official_title": "National Taiwan University Hospital Yu-Lin Branch", 
        "overall_contact": {
            "email": "chouyuhsiang@yahoo.com.tw", 
            "last_name": "Yu-Hsiang Chou, MD", 
            "phone": "+886-972655372"
        }, 
        "overall_official": {
            "affiliation": "NTUH Yun-Lin branch", 
            "last_name": "Yu-Hsiang Chou, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Taiwan: Department of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Renal function recovery (BUN, Cre)", 
            "safety_issue": "No", 
            "time_frame": "1 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02061566"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Taiwan University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Taiwan University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}